China Approves Record New Cancer, Orphan Drugs In 2020 But Access Challenges Remain

Rare Disease Therapies Nearly Double

22 Jan 2021

Throughout 2020, China’s drive to introduce more and newer drugs to the market did not slow but was rather accelerated by the COVID-19 pandemic. But can people afford them?

CHINA APPROVES RECORD NEW DRUGS IN 2020 BUT ACCESS REMAINS A CHALLENGE • Source: Shutterstock

In a bid to introduce more innovative therapies to the country, China granted more green lights to new drugs in 2020, despite the global pandemic and the devotion of considerable attention to fight the outbreak.

The 49 new drugs approved in China was close to the report card from the US FDA, which granted the...